Through this Australia Fellowship, Prof Keall and his tream will substantially improve the accuracy and effectiveness of radiation therapy for cancer by developing new techniques that will be able to ‘target’ a tumour in real-time and ‘concentrate fire’ on the most resistant and aggressive parts of it. Success in physiological targeting will create a paradigm shift in radiation therapy and could literally be a lifesaver. It’s a big challenge, but if this five-year research program succeeds, it w ....Through this Australia Fellowship, Prof Keall and his tream will substantially improve the accuracy and effectiveness of radiation therapy for cancer by developing new techniques that will be able to ‘target’ a tumour in real-time and ‘concentrate fire’ on the most resistant and aggressive parts of it. Success in physiological targeting will create a paradigm shift in radiation therapy and could literally be a lifesaver. It’s a big challenge, but if this five-year research program succeeds, it will pay big dividendsRead moreRead less
My goal is to develop substantial Australian capacity and international leadership in research on Health Impacts of Environment and Climate Change. Climate change poses diverse health risks, both direct (heatwaves, weather disasters, drought, urban air quality) and indirect (infectious disease patterns, food yields, economic loss, environmental refugee flows). My research group, with my own international connections and our strong cross-campus and external collaborative links, is ideally placed ....My goal is to develop substantial Australian capacity and international leadership in research on Health Impacts of Environment and Climate Change. Climate change poses diverse health risks, both direct (heatwaves, weather disasters, drought, urban air quality) and indirect (infectious disease patterns, food yields, economic loss, environmental refugee flows). My research group, with my own international connections and our strong cross-campus and external collaborative links, is ideally placed to do this research. Major outcomes will be: (i) enhanced understanding of the health risks from climate change and other human-induced environmental changes (including studies of their influences on patterns of infectious diseases); (ii) a broader evidence base for developing preventive-adaptive strategies to lessen health risks – and further development of my Centre’s high-level skills in translating research to social policy. My four specific aims are to: 1. Extend our research on the health impacts of climate change and other environmental changes. This will include strengthening further our international collaboration, developing new methods, and: (a) research on the health impacts of long-term drought in rural Australia; (b) elucidating the interplay of environmental, climatic, social and economic influences on infectious disease emergence and spread in the Australia-Asia region (to enhance ecological understanding, facilitate prevention-control strategies, and advance the biosecurity research agenda – including via ANU’s new Centre for Biosecurity). 2. Develop further our research on environmental and genetic influences on immune system function and autoimmune diseases, including studying the role of vitamin D. Answers to these research questions will be generalisable to the prevention and management of immune disorders. 3. Provide strong leadership in fostering international research activities, capacity and collaboration on the health impacts of global environmental-climatic changes (GEC). I have special opportunity and responsibility as co-chair of the International Council of Science project: ‘GEC and Human Health’. 4. Develop Australia’s population health research capacity with emphasis on training early-mid-career researchers. This fellowship research program would be greatly strengthened by retention of several high-performing and committed Team Investigators already working in the topic area. My central objective is to consolidate national research capacity and long-term momentum in the above areas, with high international engagement and profile. Under my directorship NCEPH has attained high visibility in: (i) climate change and health research; (ii) modeling infectious disease transmission and control; (iii) studying the environmental aetiology of immune disorders; and (iv) social-cultural epidemiological research into influences on health-reRead moreRead less
Treatments that target cancer causing genes called oncogenes have resulted in new treatment paradigms for cancer. We suggest that outcomes of patients with cancer will be further substantially improved by understanding how cancers can overcome resistance to these treatments that develops in many patients. To accelerate the adoption of these and other new treatments for cancer we will also develop new frameworks for clinical trials.
Strategies For Enhancing The Treatment Of Colon Cancer.
Funder
National Health and Medical Research Council
Funding Amount
$590,785.00
Summary
Colorectal cancer is the third leading cause of cancer related death in Australia. Strategies to improve outcomes for these patients are urgently needed. This NHMRC SRF Fellowship will seek to identify new molecules in cancer cells which can be targeted to treat this disease, and to discover genes which can be used to improve patient response to treatment.
Utilization Of Gene-engineered T Cells For Enhancing Cancer Immunotherapy
Funder
National Health and Medical Research Council
Funding Amount
$761,656.00
Summary
Killer T lymphocytes can penetrate tumours and their transfer into cancer patients has demonstrated some encouraging results, but this form of therapy and other approaches including vaccination remain ineffective in most cancer patients. In this project, we propose to improve the tumour trafficking and anti-tumour activities of killer cells by genetically engineering them with proteins that will enable them to recognise and destroy cancer cells, whilst minimizing toxicity to normal tissue.
New Strategies For Enhancing Chimeric Antigen Receptor (CAR) T Cell Therapy For Cancer
Funder
National Health and Medical Research Council
Funding Amount
$849,540.00
Summary
The role of the immune system in cancer is now recognised as highly important, highlighted by the success of immunotherapy in patients. Yet many patients fail to respond to this form of treatment due to low frequency of lymphocytes present at the tumor site. A new form of immunotherapy involving transfer of gene-modified lymphocytes is a potential way to overcome this problem. This project will explore new strategies to enhance the utility of this approach against blood and solid cancers.
I am a cellular immunologist interested in the study of cytokines and other regulatory molecules in inflammatory and immune responses. One key area relates to the effect on sunlight on cell-mediated immunity.
Integrated Basic And Clinical Cardiovascular Research For The Development Of Innovative Approaches To The Treatment Of Heart Failure
Funder
National Health and Medical Research Council
Funding Amount
$925,346.00
Summary
Heart failure (HF) is a common cardiovascular problem which causes disabling symptoms and reduces life expectancy. HF is the commonest cause or contributor to hospitalization in people over 65 years. For patients with advanced HF, survival is worse than that for aggresive cancers. At present, for patients with advanced HF and its complications, there are very few treatment options. Over the next 5 years I will conduct a comprehensive series of studies in animal models and in patients to develop ....Heart failure (HF) is a common cardiovascular problem which causes disabling symptoms and reduces life expectancy. HF is the commonest cause or contributor to hospitalization in people over 65 years. For patients with advanced HF, survival is worse than that for aggresive cancers. At present, for patients with advanced HF and its complications, there are very few treatment options. Over the next 5 years I will conduct a comprehensive series of studies in animal models and in patients to develop new treatment options.Read moreRead less
There is a need to improve early detection, monitoring of relapse, and treatments for melanoma, to increase long-term survival. My research vision is to use innovative and cutting edge approaches to conduct a range of complementary studies under three broad but inter-related themes: Theme 1 – Genetic predisposition to melanoma in the general population; Theme 2 – Genetic predisposition to melanoma in high-density families; Theme 3 – Somatic aberrations underlying melanoma development.
The goal of this research is to improve outcomes for people at risk of becoming blind or visually impaired. The focus is on those who require a corneal transplant, or who suffer from inflammatory eye disease or painful disease of the ocular surface, on neonates with retinopathy of prematurity, or those with the eye disease, keratoconus. We will investigate new treatment options for eye diseases and will examine the evidence for the success of surgical and other therapeutic interventions.